NO981864L - Oppl°sningsmetoder - Google Patents
Oppl°sningsmetoderInfo
- Publication number
- NO981864L NO981864L NO981864A NO981864A NO981864L NO 981864 L NO981864 L NO 981864L NO 981864 A NO981864 A NO 981864A NO 981864 A NO981864 A NO 981864A NO 981864 L NO981864 L NO 981864L
- Authority
- NO
- Norway
- Prior art keywords
- sningsmetoder
- upl
- proteins
- biologically active
- active compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9521805.3A GB9521805D0 (en) | 1995-10-25 | 1995-10-25 | Solubilisation methods |
| PCT/GB1996/002609 WO1997015289A1 (en) | 1995-10-25 | 1996-10-25 | Solubilisation methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO981864D0 NO981864D0 (no) | 1998-04-24 |
| NO981864L true NO981864L (no) | 1998-06-24 |
Family
ID=10782854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO981864A NO981864L (no) | 1995-10-25 | 1998-04-24 | Oppl°sningsmetoder |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0857061A1 (ja) |
| JP (1) | JP2000502990A (ja) |
| KR (1) | KR19990067028A (ja) |
| CN (1) | CN1202818A (ja) |
| AU (1) | AU704292B2 (ja) |
| BR (1) | BR9611343A (ja) |
| CA (1) | CA2235487A1 (ja) |
| GB (1) | GB9521805D0 (ja) |
| NO (1) | NO981864L (ja) |
| NZ (1) | NZ320442A (ja) |
| WO (1) | WO1997015289A1 (ja) |
| ZA (1) | ZA969016B (ja) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9605709D0 (en) * | 1996-03-19 | 1996-05-22 | Cortecs Ltd | Method |
| US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
| US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
| WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
| EP2020990B1 (en) | 2006-05-30 | 2010-09-22 | Intarcia Therapeutics, Inc | Two-piece, internal-channel osmotic delivery system flow modulator |
| EP2363112B8 (en) | 2006-08-09 | 2018-11-21 | Intarcia Therapeutics, Inc. | Osmotic delivery systems and piston assemblies |
| MX2009011123A (es) | 2007-04-23 | 2009-11-02 | Intarcia Therapeutics Inc | Formulaciones de suspensiones de peptidos insulinotropicos y sus usos. |
| DK2240155T3 (da) | 2008-02-13 | 2012-09-17 | Intarcia Therapeutics Inc | Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler |
| MX352878B (es) | 2009-09-28 | 2017-12-13 | Intarcia Therapeutics Inc | Establecimiento y/o terminacion rapidos de suministro de estado estable sustancial de farmaco. |
| US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
| US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
| MX2017015504A (es) | 2015-06-03 | 2018-05-15 | Intarcia Therapeutics Inc | Sistemas de colocacion y remoción de implante. |
| WO2017200943A1 (en) | 2016-05-16 | 2017-11-23 | Intarcia Therapeutics, Inc. | Glucagon-receptor selective polypeptides and methods of use thereof |
| USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
| USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
| IL307966A (en) | 2017-01-03 | 2023-12-01 | Intarcia Therapeutics Inc | Methods involving continuous administration of a GLP-1 receptor agonist and co-administration of a drug |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0012115A1 (de) * | 1978-12-04 | 1980-06-11 | Ciba-Geigy Ag | Pharmazeutische Präparate zur topischen Behandlung von Virusinfektionen |
| US4411882A (en) * | 1978-12-21 | 1983-10-25 | Sandoz Ltd. | Galenical compositions |
-
1995
- 1995-10-25 GB GBGB9521805.3A patent/GB9521805D0/en active Pending
-
1996
- 1996-10-25 CN CN96198527A patent/CN1202818A/zh active Pending
- 1996-10-25 JP JP9516406A patent/JP2000502990A/ja active Pending
- 1996-10-25 NZ NZ320442A patent/NZ320442A/en unknown
- 1996-10-25 ZA ZA9609016A patent/ZA969016B/xx unknown
- 1996-10-25 KR KR1019980702965A patent/KR19990067028A/ko not_active Application Discontinuation
- 1996-10-25 EP EP96935083A patent/EP0857061A1/en not_active Withdrawn
- 1996-10-25 BR BR9611343-0A patent/BR9611343A/pt not_active Application Discontinuation
- 1996-10-25 WO PCT/GB1996/002609 patent/WO1997015289A1/en not_active Application Discontinuation
- 1996-10-25 CA CA002235487A patent/CA2235487A1/en not_active Abandoned
- 1996-10-25 AU AU73178/96A patent/AU704292B2/en not_active Ceased
-
1998
- 1998-04-24 NO NO981864A patent/NO981864L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997015289A1 (en) | 1997-05-01 |
| KR19990067028A (ko) | 1999-08-16 |
| NO981864D0 (no) | 1998-04-24 |
| JP2000502990A (ja) | 2000-03-14 |
| ZA969016B (en) | 1998-04-28 |
| EP0857061A1 (en) | 1998-08-12 |
| GB9521805D0 (en) | 1996-01-03 |
| BR9611343A (pt) | 1999-12-28 |
| AU704292B2 (en) | 1999-04-15 |
| CN1202818A (zh) | 1998-12-23 |
| CA2235487A1 (en) | 1997-05-01 |
| NZ320442A (en) | 1999-10-28 |
| AU7317896A (en) | 1997-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO981864L (no) | Oppl°sningsmetoder | |
| DE69104777D1 (de) | Orale Arzneimittelformen von biologisch aktiven Eiweisstoffen. | |
| DK0730406T3 (da) | Mikrokapsler indeholdende suspensioner af biologisk aktive forbindelser | |
| BR0207776A (pt) | Derivado de esterol, lipossomos compreendendo o mesmo, método de carga dos referidos lipossomos e uso dos mesmos | |
| ATE203025T1 (de) | Reverse-turnmimetika und damit zusammenhängendes verfahren | |
| DK0600866T3 (da) | Præparater og fremgangsmåder til identifikation af biologisk aktive molekyler | |
| ES2088160T3 (es) | Formulacion y proceso quimicos. | |
| DK366889A (da) | Peptidderivat | |
| TR199701567T1 (xx) | Rapamisin t�revleri. | |
| ES2125233T3 (es) | Tratamiento de las infecciones retrovirales humanas con 2',3'-didesoxiinosina. | |
| KR970702868A (ko) | 폴리피롤카복스아미도 나프탈렌 유도체에 연결함으로써 생유용성을 증진시킨 생물학적 활성 화합물(Increased bioavailability of biologically active compounds by linking to polypyrrole-carboxamidonaphthalene derivatives) | |
| ES2148259T3 (es) | Pro-profarmacos, su produccion y uso. | |
| ES2176456T3 (es) | Procedimiento de preparacion de un compuesto inhibidor del vih proteasa. | |
| NO982567D0 (no) | Forbedret hydrogenolyse av 2,4,6,8,10,12-heksaazatetracyklo (5.5.0.05.903.11) dodekan | |
| DE3863366D1 (de) | Antibiotikum vermisporin, verfahren zu dessen herstellung und dasselbe als aktiver antibakterieller wirkstoff enthaltende pharmazeutische zusammensetzung. | |
| FI961437A0 (fi) | Vaikuttavan aineen luovuttava systeemi | |
| ES2107284T3 (es) | Nuevas n-piridil-carboxamidas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
| SE9501285L (sv) | Förfarande för framställning av biologiskt aktiva proteiner | |
| AU4515996A (en) | Methods for increasing the bioavailability of biological active agents | |
| NO902626L (no) | Fremgangsmaate for stabilisering av biologisk aktive forbindelser immobilisert paa faste faser. | |
| NO884721L (no) | Fremgangsmaate ved fremstilling av biologisk aktive komponenter. | |
| NO982927D0 (no) | Biologisk aktive benzotiazolon etanaminer | |
| TR199701298T1 (xx) | Tetralinler. | |
| FI900097A0 (fi) | Foerfarande foer bestaemning av den fibrin upploesande totalaktiviteten i plasma. | |
| KR970006251A (ko) | 고단백 유기질 비료의 제조방법 |